» Articles » PMID: 33621262

Berberine Ameliorates Vascular Dysfunction by a Global Modulation of LncRNA and MRNA Expression Profiles in Hypertensive Mouse Aortae

Overview
Journal PLoS One
Date 2021 Feb 23
PMID 33621262
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The current study investigated the mechanism underlying the therapeutic effects of berberine in the vasculature in hypertension.

Methods: Angiotensin II (Ang II)-loaded osmotic pumps were implanted in C57BL/6J mice with or without berberine administration. Mouse aortae were suspended in myograph for force measurement. Microarray technology were performed to analyze expression profiles of lncRNAs and mRNAs in the aortae. These dysregulated expressions were then validated by qRT-PCR. LncRNA-mRNA co-expression network was constructed to reveal the specific relationships.

Results: Ang Ⅱ resulted in a significant increase in the blood pressure of mice, which was suppressed by berberine. The impaired endothelium-dependent aortic relaxation was restored in hypertensive mice. Microarray data revealed that 578 lncRNAs and 554 mRNAs were up-regulated, while 320 lncRNAs and 377 mRNAs were down-regulated in the aortae by Ang Ⅱ; both were reversed by berberine treatment. qRT-PCR validation results of differentially expressed genes (14 lncRNAs and 6 mRNAs) were completely consistent with the microarray data. GO analysis showed that these verified differentially expressed genes were significantly enriched in terms of "cellular process", "biological regulation" and "regulation of biological process", whilst KEGG analysis identified vascular function-related pathways including cAMP signaling pathway, cGMP-PKG signaling pathway, and calcium signaling pathway etc. Importantly, we observed that lncRNA ENSMUST00000144849, ENSMUST00000155383, and AK041185 were majorly expressed in endothelial cells.

Conclusion: The present results suggest that the five lncRNAs ENSMUST00000144849, NR_028422, ENSMUST00000155383, AK041185, and uc.335+ might serve critical regulatory roles in hypertensive vasculature by targeting pivotal mRNAs and subsequently affecting vascular function-related pathways. Moreover, these lncRNAs were modulated by berberine, therefore providing the novel potential therapeutic targets of berberine in hypertension. Furthermore, lncRNA ENSMUST00000144849, ENSMUST00000155383, and AK041185 might be involved in the preservation of vascular endothelial cell function.

Citing Articles

The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.

Jin Z, Lan Y, Li J, Wang P, Xiong X Chin Med. 2024; 19(1):150.

PMID: 39468572 PMC: 11520704. DOI: 10.1186/s13020-024-01022-9.


Exploring the therapeutic effect of core components in Xuanshen Yishen mixture on hypertension through network pharmacology.

Wang H, Zhu M, Hou Y, Han M, Zhang L Am J Transl Res. 2024; 16(7):2877-2888.

PMID: 39114699 PMC: 11301474. DOI: 10.62347/MZGO7330.


Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Ai X, Yu P, Peng L, Luo L, Liu J, Li S Front Pharmacol. 2022; 12:762654.

PMID: 35370628 PMC: 8964367. DOI: 10.3389/fphar.2021.762654.


Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of "Vascular Memory".

Pothen L, Verdoy R, De Mulder D, Esfahani H, Farah C, Michel L Front Cardiovasc Med. 2022; 9:854361.

PMID: 35360022 PMC: 8964264. DOI: 10.3389/fcvm.2022.854361.


LncRNA ENSMUST00000155383 is Involved in the Improvement of DPP-4 Inhibitor MK-626 on Vascular Endothelial Function by Modulating Cacna1c-Mediated Ca Influx in Hypertensive Mice.

Zhang Y, Tan N, Zong Y, Li L, Zhang Y, Liu J Front Mol Biosci. 2021; 8:724225.

PMID: 34368236 PMC: 8343177. DOI: 10.3389/fmolb.2021.724225.

References
1.
Li X, Zhang L, Liang J . Unraveling the Expression Profiles of Long Noncoding RNAs in Rat Cardiac Hypertrophy and Functions of lncRNA BC088254 in Cardiac Hypertrophy Induced by Transverse Aortic Constriction. Cardiology. 2016; 134(2):84-98. DOI: 10.1159/000443370. View

2.
Zhang X, Yang X, Lin Y, Suo M, Gong L, Chen J . Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension. Int J Clin Exp Pathol. 2015; 8(6):6981-7. PMC: 4525921. View

3.
Cao D, Liu M, Duan R, Tao Y, Zhou J, Fang W . The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation. Acta Pharmacol Sin. 2019; 41(1):22-33. PMC: 7471439. DOI: 10.1038/s41401-019-0284-y. View

4.
Suhasini A, Wang L, Holder K, Lin A, Bhatnagar H, Kim S . A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma. Leukemia. 2015; 30(3):617-626. PMC: 4775385. DOI: 10.1038/leu.2015.302. View

5.
Dharmashankar K, Widlansky M . Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010; 12(6):448-55. PMC: 2982873. DOI: 10.1007/s11906-010-0150-2. View